Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology.

IF 2 4区 医学 Q4 MEDICAL INFORMATICS
Hiroko Yaegashi, Yukikazu Hayashi, Makoto Takeda, Shih-Wei Chiu, Haruhiko Nakayama, Hiroyuki Ito, Atsushi Takano, Masahiro Tsuboi, Koji Teramoto, Hiroyuki Suzuki, Tatsuya Kato, Hiroshi Yasui, Fumitaka Nagamura, Yataro Daigo, Takuhiro Yamaguchi
{"title":"Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology.","authors":"Hiroko Yaegashi, Yukikazu Hayashi, Makoto Takeda, Shih-Wei Chiu, Haruhiko Nakayama, Hiroyuki Ito, Atsushi Takano, Masahiro Tsuboi, Koji Teramoto, Hiroyuki Suzuki, Tatsuya Kato, Hiroshi Yasui, Fumitaka Nagamura, Yataro Daigo, Takuhiro Yamaguchi","doi":"10.1007/s43441-024-00671-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Clinical trials have become larger and more complex. Thus, eSource should be used to enhance efficiency. This study aimed to evaluate the impact of the multisite implementation of eSource direct data capture (DDC), which we define as eCRFs for direct data entry in this study, on efficiency by analyzing data from a single investigator-initiated clinical trial in oncology.</p><p><strong>Methods: </strong>Operational data associated with the targeted study conducted in Japan was used to analyze time from data occurrence to data entry and data finalization, and number of visits to the site and time spent at the site by clinical research associates (CRAs). Additionally, simulations were performed on the change in hours at the clinical sites during the implementation of eSource DDC.</p><p><strong>Results: </strong>No difference in time from data occurrence to data entry was observed between the DDC and the transcribed data fields. However, the DDC fields could be finalized 4 days earlier than the non-DDC fields. Additionally, although no difference was observed in the number of visits for source data verification (SDV) by CRAs, a comparison among sites that introduced eSource DDC and those that did not showed that the time spent at the site for SDV was reduced. Furthermore, the simulation results indicated that even a small amount of data to be collected or a small percentage of DDC-capable items may lead to greater efficiency when the number of subjects per site is significant.</p><p><strong>Conclusions: </strong>The implementation of eSource DDC may enhance efficiency depending on the study framework and type and number of items to be collected.</p>","PeriodicalId":23084,"journal":{"name":"Therapeutic innovation & regulatory science","volume":" ","pages":"1031-1041"},"PeriodicalIF":2.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11530566/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic innovation & regulatory science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s43441-024-00671-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Clinical trials have become larger and more complex. Thus, eSource should be used to enhance efficiency. This study aimed to evaluate the impact of the multisite implementation of eSource direct data capture (DDC), which we define as eCRFs for direct data entry in this study, on efficiency by analyzing data from a single investigator-initiated clinical trial in oncology.

Methods: Operational data associated with the targeted study conducted in Japan was used to analyze time from data occurrence to data entry and data finalization, and number of visits to the site and time spent at the site by clinical research associates (CRAs). Additionally, simulations were performed on the change in hours at the clinical sites during the implementation of eSource DDC.

Results: No difference in time from data occurrence to data entry was observed between the DDC and the transcribed data fields. However, the DDC fields could be finalized 4 days earlier than the non-DDC fields. Additionally, although no difference was observed in the number of visits for source data verification (SDV) by CRAs, a comparison among sites that introduced eSource DDC and those that did not showed that the time spent at the site for SDV was reduced. Furthermore, the simulation results indicated that even a small amount of data to be collected or a small percentage of DDC-capable items may lead to greater efficiency when the number of subjects per site is significant.

Conclusions: The implementation of eSource DDC may enhance efficiency depending on the study framework and type and number of items to be collected.

Abstract Image

肿瘤学研究者发起的临床试验中 eSource 直接数据采集的效率。
背景:临床试验的规模越来越大,也越来越复杂。因此,应使用 eSource 来提高效率。本研究旨在通过分析一项由研究者发起的肿瘤学临床试验的数据,评估多站点实施 eSource 直接数据采集(DDC)对效率的影响:方法:使用在日本开展的目标研究的相关操作数据,分析从数据发生到数据录入和数据最终完成的时间,以及临床研究助理(CRA)访问现场的次数和在现场花费的时间。此外,还对实施 eSource DDC 期间临床研究机构的工作时间变化进行了模拟:结果:DDC 和转录数据字段从数据发生到数据录入的时间没有差异。但是,DDC 字段比非 DDC 字段提前 4 天完成。此外,虽然在 CRA 进行源数据验证(SDV)的访问次数上没有发现差异,但对引入 eSource DDC 和未引入 eSource DDC 的站点进行比较后发现,在站点进行 SDV 所花费的时间有所减少。此外,模拟结果表明,当每个站点的受试者数量较多时,即使需要收集的数据量较少或支持 DDC 的项目比例较低,也能提高效率:实施 eSource DDC 可能会提高效率,这取决于研究框架以及需要收集的项目类型和数量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic innovation & regulatory science
Therapeutic innovation & regulatory science MEDICAL INFORMATICS-PHARMACOLOGY & PHARMACY
CiteScore
3.40
自引率
13.30%
发文量
127
期刊介绍: Therapeutic Innovation & Regulatory Science (TIRS) is the official scientific journal of DIA that strives to advance medical product discovery, development, regulation, and use through the publication of peer-reviewed original and review articles, commentaries, and letters to the editor across the spectrum of converting biomedical science into practical solutions to advance human health. The focus areas of the journal are as follows: Biostatistics Clinical Trials Product Development and Innovation Global Perspectives Policy Regulatory Science Product Safety Special Populations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信